Director Upstream Product Marketing PSMA Late Stage

Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company focused on delivering precision medicine through targeted radiation. The Director of Upstream Product Marketing for PSMA Late Stage will lead the commercial vision and strategy for late-stage PSMA imaging products, ensuring alignment between product development and market needs.

Responsibilities:

• Lead the development, refinement, and execution of commercial and lifecycle strategies for Illuccix®, Gozellix®, and late-stage PSMA programs
• Serve as the primary commercial thought leader guiding market evolution, competitive positioning, and long-range franchise strategy. Working closely with the Global Commercial PSMA team
• Build and steward a deep understanding of customer segments—including imaging centers, urology networks, and integrated specialty groups—to shape portfolio and pipeline decisions
• Partner with regional leaders and medical counterparts to proactively identify evidence needs and influence data-generation priorities
• Own the development and executive-level delivery of business cases, TAM/SAM analyses, value assessments, and lifecycle scenario modeling
• Collaborate with Commercial Strategy & Operations to pressure-test, align, and update late-stage forecasts and financial assumptions
• Anticipate market trends, competitive shifts, and adoption patterns to inform PMC submissions and investment decisions
• Convert complex commercial analyses into clear, strategic recommendations for regional leadership teams
• Act as the senior commercial partner to GDLs, ensuring late-stage development aligns with market needs, differentiation strategy, and launch readiness
• Lead cross-functional governance with Medical Affairs, Regulatory, Market Access, and Marketing Operations to ensure regional alignment across lifecycle activities
• Oversee commercial contributions to Launch Readiness Reviews (LRRs) and drive post-launch optimization frameworks
• Ensure a seamless upstream-to-downstream transition by aligning GTM strategy, messaging, and operational scaling across regions
• Oversee the synthesis of competitive intelligence, including clinical progress, regulatory events, launch timing, messaging, and technology advances
• Provide strategic insights that shape brand positioning, lifecycle prioritization, and risk mitigation plans
• Monitor policy, reimbursement, and market access shifts to anticipate barriers and opportunities for PSMA imaging adoption
• Lead high-impact strategic initiatives such as lifecycle indication launches, expansion projects, and multi-regional alignment activities
• Drive execution excellence by setting timelines, governance structures, and communication standards for cross-functional teams
• Present strategic updates, insights, and recommendations to executive leadership and participate in PMC and portfolio governance forums

Requirements:

• Bachelor's degree in Marketing, Business, or Life Sciences; MBA or advanced degree strongly preferred
• 8–12+ years of experience in pharmaceutical, biotech, molecular imaging, medical device or diagnostics marketing, ideally in oncology or urology
• Proven experience leading upstream product strategy, lifecycle management, or commercial planning for late-stage assets
• Strong ability to synthesize scientific, clinical, communicate commercial insights into strategic decision-making
• Demonstrated success influencing cross-functional teams in complex, matrixed environments
• Strong financial and analytical acumen, with experience developing sophisticated forecasts and investment cases
• Exceptional communication, executive presentation, and stakeholder leadership skills
• Advanced project leadership and organizational capabilities